Literature DB >> 12819470

Hyper IgM syndromes.

A Virginia Gulino1, Luigi D Notarangelo.   

Abstract

The immune defense against extracellular pathogens is largely dependent on antibody production. Class switch recombination and somatic hypermutation shape the secondary antibody repertoire in peripheral lymphoid tissue. In the past few years, a series of primary immune deficiencies characterized by defects in these processes and collectively referred to as hyper-IgM syndromes, have been described. Careful investigation of these rare "experiments of nature" has enabled to identify novel genes and molecular events that drive terminal B-cell differentiation. Abnormalities in these genes are likely involved also in lymphoid tumorigenesis and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819470     DOI: 10.1097/00002281-200307000-00009

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  18 in total

1.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Authors:  Dimitris Panagopoulos; Panayiotis Victoratos; Maria Alexiou; George Kollias; George Mosialos
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 4.  Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.

Authors:  Mohamed-Ridha Barbouche; Qubo Chen; Marco Carbone; Imen Ben-Mustapha; Zakera Shums; Mehdi Trifa; Federica Malinverno; Francesca Bernuzzi; Haiyan Zhang; Nourhen Agrebi; Gary L Norman; Christopher Chang; M Eric Gershwin; Pietro Invernizzi
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

5.  Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.

Authors:  Greta Meyers; Yen-Shing Ng; Jason M Bannock; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Sara S Kilic; Guzide Aksu; Marianne Debré; Frédéric Rieux-Laucat; Mary Ellen Conley; Charlotte Cunningham-Rundles; Anne Durandy; Eric Meffre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-23       Impact factor: 11.205

Review 6.  Molecular- and flow cytometry-based diagnosis of primary immunodeficiency disorders.

Authors:  Joao B Oliveira; Thomas A Fleisher
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

7.  Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.

Authors:  Tineke Cantaert; Jean-Nicolas Schickel; Jason M Bannock; Yen-Shing Ng; Christopher Massad; Fabien R Delmotte; Natsuko Yamakawa; Salome Glauzy; Nicolas Chamberlain; Tuure Kinnunen; Laurence Menard; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Julie Bruneau; Waleed Al-Herz; Sara Sebnem Kilic; Hans D Ochs; Charlotte Cunningham-Rundles; Mirjam van der Burg; Taco W Kuijpers; Sven Kracker; Hideo Kaneko; Yujin Sekinaka; Shigeaki Nonoyama; Anne Durandy; Eric Meffre
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

Review 8.  Genetic and hormonal factors in female-biased autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; John W Kappler; Philippa Marrack
Journal:  Autoimmun Rev       Date:  2010-02-06       Impact factor: 9.754

9.  Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease.

Authors:  Cindy S Ma; Stefania Pittaluga; Danielle T Avery; Nathan J Hare; Irina Maric; Amy D Klion; Kim E Nichols; Stuart G Tangye
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

Review 10.  The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases.

Authors:  Eric Meffre
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.